Discovery of PH-797804, a highly selective and potent inhibitor of p38 MAP kinase
Shaun R. Selness(Pfizer (United States)), Rajesh Devraj(Pfizer (United States)), Balekudru Devadas(Pfizer (United States)), John K. Walker(Pfizer (United States)), Terri L. Boehm(Pfizer (United States)), Richard C. Durley(Pfizer (United States)), H.-S. Shieh(Pfizer (United States)), Lei Xing(Pfizer (United States)), Paul V. Rucker(Pfizer (United States)), Kevin D. Jerome(Pfizer (United States)), Alan G. Benson(Pfizer (United States)), Laura D. Marrufo(Pfizer (United States)), Heather M. Madsen(Pfizer (United States)), Jeff Hitchcock(Pfizer (United States)), Tom J. Owen(Pfizer (United States)), Lance C. Christie(Pfizer (United States)), Michele A. Promo(Pfizer (United States)), Brian S. Hickory(Pfizer (United States)), Edgardo Alvira(Pfizer (United States)), Win Naing(Pfizer (United States)), Radhika Blevis-Bal(Pfizer (United States)), Dean Messing(Pfizer (United States)), Jerry Z. Yang(Pfizer (United States)), Michael K. Mao(Pfizer (United States)), Gopi Yalamanchili(Pfizer (United States)), Richard Vonder Embse(Pfizer (United States)), Jeffrey Hirsch(Pfizer (United States)), Matthew J. Saabye(Pfizer (United States)), Sheri L. Bonar(Pfizer (United States)), Elizabeth Webb(Pfizer (United States)), Gary D. Anderson(Pfizer (United States)), Joseph B. Monahan(Pfizer (United States))
Cited by 71Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis